These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 33882808)

  • 1. Do Naturally Occurring Antioxidants Protect Against Neurodegeneration of the Dopaminergic System? A Systematic Revision in Animal Models of Parkinson's Disease.
    Costas C; Faro LRF
    Curr Neuropharmacol; 2022; 20(2):432-459. PubMed ID: 33882808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial Effects of Flavonoids Against Parkinson's Disease.
    Jung UJ; Kim SR
    J Med Food; 2018 May; 21(5):421-432. PubMed ID: 29412767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abrogating Oxidative Stress as a Therapeutic Strategy Against Parkinson's Disease: A Mini Review of the Recent Advances on Natural Therapeutic Antioxidant and Neuroprotective Agents.
    Theofanous T; Kourti M
    Med Chem; 2022; 18(7):772-783. PubMed ID: 35249501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combating Parkinson's disease with plant-derived polyphenols: Targeting oxidative stress and neuroinflammation.
    Gahtani RM; Shoaib S; Hani U; Jayachithra R; Alomary MN; Chauhan W; Jahan R; Tufail S; Ansari MA
    Neurochem Int; 2024 Sep; 178():105798. PubMed ID: 38950626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plant Polyphenols as Neuroprotective Agents in Parkinson's Disease Targeting Oxidative Stress.
    Hor SL; Teoh SL; Lim WL
    Curr Drug Targets; 2020; 21(5):458-476. PubMed ID: 31625473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. l-Theanine ameliorates motor deficit, mitochondrial dysfunction, and neurodegeneration against chronic tramadol induced rats model of Parkinson's disease.
    Raj K; Gupta GD; Singh S
    Drug Chem Toxicol; 2022 Sep; 45(5):2097-2108. PubMed ID: 34210222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances on the neuroprotective potential of antioxidants in experimental models of Parkinson's disease.
    Koppula S; Kumar H; More SV; Kim BW; Kim IS; Choi DK
    Int J Mol Sci; 2012; 13(8):10608-10629. PubMed ID: 22949883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective strategies in Parkinson's disease : an update on progress.
    Mandel S; Grünblatt E; Riederer P; Gerlach M; Levites Y; Youdim MB
    CNS Drugs; 2003; 17(10):729-62. PubMed ID: 12873156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isothiocyanates Are Promising Compounds against Oxidative Stress, Neuroinflammation and Cell Death that May Benefit Neurodegeneration in Parkinson's Disease.
    Sita G; Hrelia P; Tarozzi A; Morroni F
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27598127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective potential of spermidine against rotenone induced Parkinson's disease in rats.
    Sharma S; Kumar P; Deshmukh R
    Neurochem Int; 2018 Jun; 116():104-111. PubMed ID: 29501454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naringenin alleviates paraquat-induced dopaminergic neuronal loss in SH-SY5Y cells and a rat model of Parkinson's disease.
    Ahmad MH; Fatima M; Ali M; Rizvi MA; Mondal AC
    Neuropharmacology; 2021 Dec; 201():108831. PubMed ID: 34655599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Nrf2 signaling pathway and oxidative stress by resveratrol for Parkinson's disease: an overview and update on new developments.
    Zamanian MY; Parra RMR; Soltani A; Kujawska M; Mustafa YF; Raheem G; Al-Awsi L; Lafta HA; Taheri N; Heidari M; Golmohammadi M; Bazmandegan G
    Mol Biol Rep; 2023 Jun; 50(6):5455-5464. PubMed ID: 37155008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The principal molecular mechanisms behind the activation of Keap1/Nrf2/ARE pathway leading to neuroprotective action in Parkinson's disease.
    Chakkittukandiyil A; Sajini DV; Karuppaiah A; Selvaraj D
    Neurochem Int; 2022 Jun; 156():105325. PubMed ID: 35278519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Arbutin Protects Against Parkinson's Disease-Associated Mitochondrial Dysfunction In Vitro and In Vivo.
    Ding Y; Kong D; Zhou T; Yang ND; Xin C; Xu J; Wang Q; Zhang H; Wu Q; Lu X; Lim K; Ma B; Zhang C; Li L; Huang W
    Neuromolecular Med; 2020 Mar; 22(1):56-67. PubMed ID: 31401719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promising Polyphenols in Parkinson's Disease Therapeutics.
    Singh A; Tripathi P; Yadawa AK; Singh S
    Neurochem Res; 2020 Aug; 45(8):1731-1745. PubMed ID: 32462543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term supplementation with plant extracts rich in flavonoids protect nigrostriatal dopaminergic neurons in a rat model of Parkinson's disease.
    Datla KP; Zbarsky V; Rai D; Parkar S; Osakabe N; Aruoma OI; Dexter DT
    J Am Coll Nutr; 2007 Aug; 26(4):341-9. PubMed ID: 17906186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective potential of chrysin in Parkinson's disease: Molecular mechanisms and clinical implications.
    Angelopoulou E; Pyrgelis ES; Piperi C
    Neurochem Int; 2020 Jan; 132():104612. PubMed ID: 31785348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tannic Acid Mitigates Rotenone-Induced Dopaminergic Neurodegeneration by Inhibiting Inflammation, Oxidative Stress, Apoptosis, and Glutamate Toxicity in Rats.
    Azimullah S; Meeran MFN; Ayoob K; Arunachalam S; Ojha S; Beiram R
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effects of multifunctional tetramethylpyrazine nitrone on models of Parkinson's disease in vitro and in vivo.
    Guo B; Xu D; Duan H; Du J; Zhang Z; Lee SM; Wang Y
    Biol Pharm Bull; 2014; 37(2):274-85. PubMed ID: 24305623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effect of omega-3 polyunsaturated fatty acids in the 6-OHDA model of Parkinson's disease is mediated by a reduction of inducible nitric oxide synthase.
    Mori MA; Delattre AM; Carabelli B; Pudell C; Bortolanza M; Staziaki PV; Visentainer JV; Montanher PF; Del Bel EA; Ferraz AC
    Nutr Neurosci; 2018 Jun; 21(5):341-351. PubMed ID: 28221817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.